The Indian pharmaceutical industry is one of the major contributors to the Indian economy and it is the world’s third-largest industry by volume. The Indian pharmaceutical industry’s success can be credited to its world-class capabilities in formulation development, entrepreneurial abilities of its people, and the vision of its business leaders to establish India’s footprint in the United States and other large international markets. The generics industry plays a critical role in enabling enhanced health outcomes throughout the world with the availability of affordable and high-quality generic drugs, achieving 60 percent of global vaccine output and approximately 40 to 70 percent of the WHO’s demand for vaccines comes from India for Diphtheria, Tetanus, and Pertussis (DPT); Bacillus Calmette-Guerin (BCG); and measles. As per the estimates, approximately one-third of all the pills consumed in the US are made in India, while approximately 25 percent of the medicines consumed in the UK are produced by Indian manufacturers. African countries with access to affordable Indian drugs have seen an increase in the number of people receiving treatment for AIDS, and 37 percent of AIDS patients in 2009 received treatment compared to just 2 percent in 2003.